Marzo 2008
• Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertens (Jan) 51:55-61, 2008
• Mittal BV, Alexander MP, Rennke HG, et al. Atheroembolic renal disease: A silent masquerader. Kidney Int (Jan) 73:126-130, 2008
• Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (Jan) 371:117-125, 2008
• Dehghan A, van Hoek M, Sijbrands EJ, et al. High serum uric acid as a novel risk factor for type 2 diabetes. Diabet Care (Feb) 31:361-362, 2008
• Brown NJ. Aldosterone and vascular inflammation. Hypertens (Feb) 51:161-167, 2008
• Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med (Jan) 148:30-48, 2008
• Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol (Jan) 3:153-158, 2008
• Holden RM, Harman GJ, Wang M, et al. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol (Jan) 3:105-110, 2008
• Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Battleground: chronic kidney disorders mineral and bone disease - calcium obsession, vitamin D, and binder confusion. Clin J Am Soc Nephrol (Jan) 3:168-173, 2008
• McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol (Jan) 3:19-26, 2008
• Palmer BF, Henrich WL. Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol (Jan) 19:8-11, 2008
• Wattanakit K, Cushman M, Stehman-Breen C, et al. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (Jan) 19:135-140, 2008
